Safety of azithromycin in pediatrics: a systematic review and meta-analysis.

Linan ZengPeipei XuImti ChoonaraZhenyan BoXiangchen PanWenyan LiXiaofeng NiTao XiongCan ChenLeshan HuangShamim Ahmad QaziDezhi MuLingli Zhang

Published in: European journal of clinical pharmacology (2020)

The safety of azithromycin as MDA needs further evaluation. The most common ADRs are diarrhea and vomiting. The risk of the most serious uncommon ADRs (cardiac-prolonged QT and IHPS) is unknown.

Keyphrases

left ventricular
breast cancer cells
drug induced
irritable bowel syndrome
signaling pathway
cell death
atrial fibrillation
cell proliferation
cell cycle arrest